{
    "table": "| Methods                                                                                                                                                                                                                                                                                                                                                                            | Participants                                                                                                                                                                                                                                   | Interventions                                                                                                                                                                                  | Outcomes                                                                                                                                                                                                               | Notes                                                                                                       |\n|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|:------------------------------------------------------------------------------------------------------------|\n| Randomized, double-blind, non-inferiority trial                                                                                                                                                                                                                                                                                                                                    | 978 women diagnosed with primary post-partum haemorrhage                                                                                                                                                                                       | 800 \u03bcg sublingual misoprostol vs. 40 IU intravenous oxytocin                                                                                                                                   | Cessation of active bleeding within 20 min and additional blood loss of 300 mL or more after treatment                                                                                                                 | All outcomes assessed from the time of initial treatment.                                                   |\n| Double-blind, placebo-controlled, randomized clinical trial                                                                                                                                                                                                                                                                                                                        | Women in labour with bleeding judged to be more than expected due to uterine atony                                                                                                                                                             | Misoprostol 5 \u00d7 200 \u00b5g or inactive placebo administered orally, buccally/sublingually, and rectally                                                                                            | Measured blood loss of 500 ml or more in the hour after enrolment, mean blood loss, 24-hour haemoglobin <6 g/dL or blood transfusion, pyrexia at 1 hour \u226538.5\u00b0C, shivering at 1 hour \u2265 moderate                        | Confidential interim analysis performed after the first 100 enrollments.                                    |\n| Randomized single blinded two-center study                                                                                                                                                                                                                                                                                                                                         | 64 women with primary postpartum hemorrhage                                                                                                                                                                                                    | Arm 1: Intra-muscular Syntometrine + Syntocinon infusion + placebo tablets per rectum. Arm 2: 800 mcg misoprostol per rectum + placebo intra-muscular injection + placebo intravenous infusion | Primary outcome: Cessation of hemorrhage within 20 minutes                                                                                                                                                             | Study terminated due to significant difference between treatment regimens.                                  |\n| Computer-generated randomisation was used to assign women to receive 600 \u03bcg misoprostol or matching placebo sublingually; both groups were also given routine injectable uterotonics. Allocation was concealed by distribution of sealed and sequentially numbered treatment packs in the order that women were enrolled. Providers and women were masked to treatment assignment. | Women delivering vaginally who had clinically diagnosed post-partum haemorrhage due to uterine atony were enrolled from participating hospitals in Argentina, Egypt, South Africa, Thailand, and Vietnam between July, 2005, and August, 2008. | Women were assigned to receive 600 \u03bcg misoprostol or matching placebo sublingually; both groups were also given routine injectable uterotonics.                                                | The primary outcome was blood loss of 500 mL or more within 60 min after randomisation.                                                                                                                                | NR                                                                                                          |\n| Study setting and patients                                                                                                                                                                                                                                                                                                                                                         | Women enrolled in Ecuador, Egypt, and Vietnam                                                                                                                                                                                                  | 800 \u03bcg sublingual misoprostol vs 40 IU intravenous oxytocin                                                                                                                                    | Primary outcome: Active bleeding cessation within 20 min, blood loss of 300 mL or more after treatment                                                                                                                 | Protocol approved by relevant ethics committees, reported in accordance with the revised CONSORT statement. |\n| Randomized controlled trial                                                                                                                                                                                                                                                                                                                                                        | 61 women diagnosed with PPH                                                                                                                                                                                                                    | Oxytocin plus 600 mcg misoprostol sublingually vs. oxytocin plus matching placebo                                                                                                              | Postpartum blood loss, change in hemoglobin, side effects, need for additional interventions including blood transfusion, additional uterotonics, balloon tamponade, hysterec- tomy, and mean blood loss               | NR                                                                                                          |\n| Women with postpartum haemorrhage were enrolled in a randomised controlled trial comparing misoprostol and placebo in addition to routine treatment.                                                                                                                                                                                                                               | Women admitted to the labour room of the Farafenni APRC Hospital, Gambia                                                                                                                                                                       | Misoprostol 600\u00b5g (200\u00b5g orally and 400\u00b5g sublingually) or placebo tablets were administered in addition to routine active management with oxytocin or syntometrine.                           | Average additional blood loss after taking study medication, frequency and severity of side effects, additional blood loss >500 mL after enrolment, clinical complications, and hemoglobin 12-24 hours after delivery. | NR                                                                                                          |"
}